Literature DB >> 24165211

History of syphilis: between poetry and medicine.

Ismael Maatouk1, Roy Moutran.   

Abstract

INTRODUCTION: The origin of syphilis is a matter of debate and two "historical" hypotheses explain its emergence. AIM: We present here a review about syphilis history.
METHODS: A review of literature about syphilis history using the following keywords: "syphilis," "history," and "treponema."
RESULTS: The Columbian opinion is that syphilis came from the New World (America) with the crews of Christopher Columbus's fleet. As Naples fell before the invading army of Charles the VIII in 1495, a plague broke out among the French leader's troops. When the army disbanded shortly after the campaign, the troops, composed largely of mercenaries, returned to their homes and disseminated the disease across Europe. Indeed, there were reports that indigenous peoples of the New World suffered from a similar condition.
CONCLUSION: Regardless of the Columbian and the Pre-Columbian theories, syphilis remains an international disease, growing nowadays with HIV infection. Despite history, politics, paleopathology and molecular approaches, the origin of the disease remains an enigma.
© 2013 International Society for Sexual Medicine.

Entities:  

Keywords:  History; Modern Risk Factors; Syphilis; Treponema Pallidum

Mesh:

Substances:

Year:  2013        PMID: 24165211     DOI: 10.1111/jsm.12354

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  2 in total

1.  Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions.

Authors:  Marianne J Middelveen; Jennie Burke; Eva Sapi; Cheryl Bandoski; Katherine R Filush; Yean Wang; Agustin Franco; Arun Timmaraju; Hilary A Schlinger; Peter J Mayne; Raphael B Stricker
Journal:  F1000Res       Date:  2014-12-18

Review 2.  [Evolution of treatment of syphilis through history].

Authors:  C Ros-Vivancos; M González-Hernández; J F Navarro-Gracia; J Sánchez-Payá; A González-Torga; J Portilla-Sogorb
Journal:  Rev Esp Quimioter       Date:  2018-11-14       Impact factor: 1.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.